Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole

Protein Science

Volumn 10, Issue 11, 2001, Pages 2200-2206

  Battistutta, Roberto ^a   De Moliner, Erika ^a   Sarno, Stefania ^a   Zanotti, Giuseppe ^a   Pinna, Lorenzo A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apo CK2; Casein kinase 2; CK2; Complexes; Emodin; Inhibitors; Protein kinase; TBB

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; BENZOTRIAZOLE DERIVATIVE; CASEIN KINASE II; EMODIN; PROTEIN KINASE;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBUNIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

ADENOSINE TRIPHOSPHATE; BINDING SITES; CASEIN KINASE II; EMODIN; ENZYME INHIBITORS; GUANOSINE TRIPHOSPHATE; MODELS, MOLECULAR; PROTEIN-SERINE-THREONINE KINASES; TRIAZOLES; ZEA MAYS;

ZEA MAYS;

EID: 0034775155     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.19601     Document Type: Article

References (33)

1. Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation
2. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2
3. Crystallography & NMR system: A new software suite for macromolecular structure determination
4. The development and therapeutic potential of protein kinase inhibitors
5. Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine
6. ATP site-directed competitive and irreversible inhibitors of protein kinases
7. Protein kinase CK2 and its role in cellular proliferation, development and pathology
8. Expression, purification and crystallization of the catalytic subunit of protein kinase CK2 from Zea mays
9. 1001 protein kinases redux towards 2000
10. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum
11. Improved methods for binding protein models in electron density maps and the location of errors in these models
12. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase II alpha
13. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine
14. PROCHECK: A program to check the stereochemical quality of protein structure
15. In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor
16. Expression of the casein kinase 2 subunits in Chinese hamster ovary and 3T3 L1 cells provides information on the role of the enzyme in cell proliferation and the cell cycle
17. Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2')
18. AmoRe: An automated package for molecular replacement
19. Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 Å resolution
20. GTP plus water mimic ATP in the active site of protein kinase CK2
21. Protein kinase CK2alpha' is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation
22. Casein kinase 2: An 'eminence grise' in cellular regulation?
23. Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation
24. Protein kinase CK2 mutants defective in substrate recognition. Purification and kinetic analysis
25. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2')
26. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase
27. Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle
28. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
29. Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CKI and CKII from Saccharomyces cerevisiae and other sources
30. Three protein kinase structures define a common motif
31. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors
32. The sequence of the human genome
33. Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties